We hypothesized that abnormalities in CML, such as decreased Icsbp/Irf8 expression, might prevent termination of a physiologically induced innate immune response; leading to CML progression. The gene discussed is IRF8; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.